{"name":"Rohto Pharmaceutical Co., Ltd.","slug":"rohto-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNeDlfakZsYWR3NWtUdUF1SXRsSTFSMy1kc2VXUE9EZmdTZFNSRXlUakI2cXhhMzBlUk1ySnFqZ0RIcDdRd3hPb3lVY0U3WmtWOWY1V3llbmtSR2FFRmx5NTJUbm8tLW4tekpvZkNQdEd3QVVKNjBpR0NqUFlyalp2YnFKMm9Tc3FtSUV4ZlF0d21aektCaHdrY1d4OFdhQjhVMGhseVFiODcxLWVaRDZIUHpod05qT2w1MGp1bEl5TV9WZw?oc=5","date":"2026-04-03","type":"pipeline","source":"AD HOC NEWS","summary":"Rohto Pharmaceutical Stock: A Stable Leader in Japan's Eye Care and OTC Market with Global Expansion - AD HOC NEWS","headline":"Rohto Pharmaceutical Stock: A Stable Leader in Japan's Eye Care and OTC Market with Global Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPeUtWOV9lSnNkWkpKWXd2T3hwQ2U5S0tvamU0aDZFQTJ2VlBxRnRIcTVlVGR3M1BJMEJmbDhzYVRmUU1NY3N0VDVZMzlFR1BOc3oxbnhJTDZSN2Z3cnZKTDA4ampBTUM3TldTc2ViVXJiNmo5T3V4Z25LcWsxMGk5dWdyWlY2aERkVVdrNlpyeU5KLXc?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Segmentation, Major Trends, and Competitive Overview of the Ophthalmic Eye Dropper Market - openPR.com","headline":"Segmentation, Major Trends, and Competitive Overview of the Ophthalmic Eye Dropper Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOVHNUMW1wOVZWSTVzYzN1UEFBYjl5MkxvSm8wVkdHczRmOEg0OGVGWGl5UUYyODdGQTRNeGIxODFuOXBxcnZ6N2lXckN4d25RQUU2dklic0M1dGtSc0R0M3EtUUFuSV92cmpGODhLVTZZOGdxV2ota0VYSzVyNTNFNUVwdVl3TlpwcWl2RDVITDZFYlMxR3lUR1pvZ2Jfc3VRWnNfd3B1aW14ZmJnMGwwMFB4TlFVYVdRdk5tS3VVOA?oc=5","date":"2026-02-10","type":"pipeline","source":"AD HOC NEWS","summary":"The Truth About Rohto Pharmaceutical Co Ltd: Why Everyone Is Suddenly Paying Attention - AD HOC NEWS","headline":"The Truth About Rohto Pharmaceutical Co Ltd: Why Everyone Is Suddenly Paying Attention","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE4tNzlFN1Rnd2hsMGdKN2s2MEpUU1FCZDVVT3J2bVRNQklFNm5TcWRwdV8tQ1VrVC1vbXFFMUpqd0g5RXUzRHBaYXNvNEI0SXRlREh1WVJmNks?oc=5","date":"2025-12-09","type":"pipeline","source":"Market.us","summary":"Eyelid Scrub Market Size, Share, Growth | CAGR of 7.0% - Market.us","headline":"Eyelid Scrub Market Size, Share, Growth | CAGR of 7.0%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQM0RxR2xicHotX1VrMDc4U2lScXJIUHBZM1drMXhtTEd6a0lPRmxnQk5vcFpObHk2YXp3aVZWejJIUlJIQnNRdGJ5WHJocGRBVURGLTdpSWpMUGp1VDR1WU1qeFRJeXZxdUxJSndBNElueHNpcGxCY3RNTDZrQkNDRWJrSjZZM3hOeFJDa2tJZzBkUGpRQzU1b3Z4Z0ZMNHFDZTlqWUdnMURqanBqTEtaeG9vZktYRTRRWnlHai1EMjNQZ0tGZU5JbmlhSGRIQTNvb205eWduV2hzVEx0Z1N4VmVCNnZzTDZoUjJrdUN5MkpxVkUwd2dxTDJNWVJFUmxtNWVYWWgzZE1rbmh2eEtN?oc=5","date":"2025-04-08","type":"pipeline","source":"Business Wire","summary":"Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively - Business Wire","headline":"Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Construct","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-01-03","type":"pipeline","source":"globenewswire.com","summary":"Dry Eye Products Market Opportunities and Strategies to - globenewswire.com","headline":"Dry Eye Products Market Opportunities and Strategies to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1EZElyekRMMTNpZkxkNEZzZkNCcjFzTHJTdW1POFFhQ1J2d0k0OHV3VUVnakdHWWF5TXNsYWgxaDE0N2N5eHdaMVo5dWVsbV9yY2k2NlJXUDZLcFVmV21kVGp1RFhuQzBtZ3c?oc=5","date":"2024-10-03","type":"trial","source":"macnica.co.jp","summary":"Case Study of Rohto Pharmaceutical Co., Ltd.: New learnings and implementation of a cross-departmental DX project - The current state of Rohto Pharmaceutical's strongly promoted initiatives - Smart Ma","headline":"Case Study of Rohto Pharmaceutical Co., Ltd.: New learnings and implementation of a cross-departmental DX project - The ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNU0xkcUxRZGRtQmRrMkRRYlJDNkRaR0JBaXRwcXdBamE2NGVNZ0xQTGhNalozNGxENEI1LWN4RFFUWEVheHJYZFdBeERaT0Etck41WFFkRTFaMVFiTE56NnpabXV1OXRIbDA3NGpTRjlvX3RIWmhYMG8wc1I1SkFxeFY2UDM0a2lfeWs3X2xqZzBBUVd4Mkd0Wl81a0FXZVNJQUZsZl9BSFY2RGswUFNqejRhSS1FaFhlYkRhRERsRHFEeVdvcFUtSGIzc3Q4SHlJNGhzT1czWQ?oc=5","date":"2024-04-08","type":"deal","source":"BioSpectrum Asia","summary":"Japanese firms Mitsui & Rohto Pharma buy Singapore-based consumer healthcare brand for ¥88 B - BioSpectrum Asia","headline":"Japanese firms Mitsui & Rohto Pharma buy Singapore-based consumer healthcare brand for ¥88 B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE93d2liaWM5cndLV2lEOHljQ3dJV0QzVU5wczlhcnl2TE1mZmxxcGdMUTRwUkVrN21VYU5VX1MtY1FUZFFYckxiSUE5VjZsdFpWN2tyMkZ5UXlLcmstVWh4WEg4Y0hkaUtlbk5oMg?oc=5","date":"2024-04-04","type":"deal","source":"mitsui.com","summary":"Mitsui to acquire Eu Yan Sang International Ltd, a leading Singapore-based consumer healthcare brand in Asia with Rohto. | 2024 | Releases - mitsui.com","headline":"Mitsui to acquire Eu Yan Sang International Ltd, a leading Singapore-based consumer healthcare brand in Asia with Rohto.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNV0FWdkwtOWNudlNiZ2ZqYUhiOXNabW1YMTF4aHBRZFVrXzVYaDEybnFycVFTZ1R2bUNhQXBLeDMyYlhQcmZHYXZsVG1PU3BtcFhEZ1NhR2VjaG9TR1hYNUM0VnV5OHJtWUx1VEJqREN3alFPTDhpX3VOU0gxT0lyTGxDZHVkMy0wT2JMVnlWNDY3VlNsNXBobmlaRHZXT1JZLW5ITm84XzFDYll4MUYzUy1XOEJEODRnS2gtNlZGSFptM3pLcTNTbDlkWkJDNVE?oc=5","date":"2024-04-04","type":"deal","source":"Reuters","summary":"Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang - Reuters","headline":"Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5DcENobzRpQjRHOWs5a1BSZ3pmOWpoRXY4QlNGdkl1dWhhUHhmNW9xajBNX0lkZkYzczFNWngyV1RZSlQ2Q0FZck1UYk5nRkNiQ0JkamZ1VlNDbjQ?oc=5","date":"2022-09-28","type":"pipeline","source":"EurekAlert!","summary":"DryEyeRhythm: A reliable, valid, and non-invasive app to assess dry eye disease - EurekAlert!","headline":"DryEyeRhythm: A reliable, valid, and non-invasive app to assess dry eye disease - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE8tTHA1ZzE3WnJGTUpNbGlpUzlINGMtamVtYXhoek5JcjAxM2hOZWktSktOcHk0bUV2S1FVYUpyV3Q2MTBCclZTSnpmRUx4RVhxaGhZZ3Y0eDJrOVZOaXVTVjZ0SU90SHkzQ0ow?oc=5","date":"2018-06-29","type":"pipeline","source":"rohto.co.jp","summary":"Results by Regions: Europe | Investor Relations | ROHTO Pharmaceutical Co., Ltd - rohto.co.jp","headline":"Results by Regions: Europe | Investor Relations | ROHTO Pharmaceutical Co., Ltd","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}